Israel Biotech Fund seeks high-value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies. Their key asset is a unique team of 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide their portfolio companies with hands-on guidance and support.

Biotechnology

Israel Biotech Fund

Co-Founders & Managing Partners

David Sidransky

Yuval Cabilly

Ido Zairi

The current board of directors for Israel Biotech Fund consists of individuals with experience in the financial, medical, and technological industries. Many of the members have experience as CEOs or Vice Presidents of companies in these industries. Some notable companies include Osmotica Pharmaceutical Corp, Edge Therapeutics, Inc, and Oceana Therapeutics, Inc. In addition, several members have experience as board members or founders of other companies. The board also includes members with various educational backgrounds, such as a degree in medicine from The Johns Hopkins University School of Medicine or a law degree from Northwestern University Pritzker School of Law.

Board of Directors

About

Team members

Other teams at Israel Biotech Fund

Leadership Team

Founding Team